John Davis

Dec 13, 2023 | ascpt.onlinelibrary.wiley.com | John Davis |Samit Ganguly |Marçal Bravo Padros |Daniela J. Conrado

Subcutaneous (SC) administration of monoclonal antibodies (mAbs) can reduce treatment burden for patients and healthcare systems compared to intravenous (IV) infusion through shorter administration times, made possible by convenient, patient-centric devices. A deeper understanding of clinical pharmacology principles related to efficacy and safety of SC-administered mAbs over the past decade has streamlined SC product development.

Sep 10, 2023 | acrjournals.onlinelibrary.wiley.com | Bradly A. Kimbrough |Science Rochester Minnesota |Cynthia S. Crowson |John Davis

Objective The focus of this study was to assess changes in the cumulative incidence of extra-articular manifestations of rheumatoid arthritis (ExRAs) and associated mortality risk. Methods This study evaluated trends in occurrence of ExRAs using a population-based inception cohort that included all adult patients with incident rheumatoid arthritis (RA) from 1985 through 2014 meeting the 1987 American College of Rheumatology criteria.